Abstract:Objective To explore the effect of overexpression of silent mating type information regulation 2 homolog-3 (SIRT3) on inhibiting cardiomyocyte senescence induced by advanced glycation end-products (AGEs) and its mechanism. Methods The primary cardiomyocytes cultured for 48 h were divided into four groups, control group, 50 μg/ml AGEs intervention group, 100 μg/ml AGEs intervention group and 200 μg/ml AGEs intervention group, which were then further intervened for 48 h. The expression levels of P16, P53 and SIRT3 were detected by Western blot, and impact of Sirt3 on senescence was explored. Primary cardiomyocytes were divided into three groups:negative control group (NC group, transfected with empty lentivirus), AGEs group (normally cultured cardiomyocytes treated with 100 μg/ml AGEs), and overexpression group (transfected with lentivirus overexpressing Sirt3 for 72 h, then treated with 100 μg/ml AGEs for 48 h). Cellular senescence levels were detected by β-galactosidase staining. The protein expression levels of P16, P53, SIRT3, and superoxide dismutase-2 (SOD2) were detected by Western blot. Intracellular reactive oxygen species (ROS) level in cardiomyocytes was determined using dihydroethidium (DHE) fluorescent probe. Each experiment was independently repeated three times. GraphPad Prism 6 software was used for statistical analysis. Comparison of measurement data among multiple groups was performed using one-way ANOVA. Results Compared with control group (AGEs 0 μg/ml), the protein expression level of P16 and P53 in cardiomyocytes increased and SIRT3 decreased after the intervention of AGEs, with statistically significant differences (all P<0.05). Compared with the AGEs group, the overexpression group showed decreased expression levels of P16 and P53, a reduced percentage of β-galactosidase staining-positive cells, and an increased SOD2 expression, and a decreased ROS production, all with statistically significant differences (all P<0.05). Conclusion Overexpression of Sirt3 can reduce oxidative stress through SIRT3/SOD2/mitochondrial ROS pathway, protecting cardiomyocytes by delaying glycation-induced senescence.